Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Notre Dame chemists discover new class of antibiotics

10.03.2014

A team of University of Notre Dame researchers led by Mayland Chang and Shahriar Mobashery have discovered a new class of antibiotics to fight bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant bacteria that threaten public health.

Their research is published in the Journal of the American Chemical Society in an article titled "Discovery of a New Class of Non-beta-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity."

The new class, called oxadiazoles, was discovered in silico (by computer) screening and has shown promise in the treatment of MRSA in mouse models of infection. Researchers who screened 1.2 million compounds found that the oxadiazole inhibits a penicillin-binding protein, PBP2a, and the biosynthesis of the cell wall that enables MRSA to resist other drugs. The oxadiazoles are also effective when taken orally. This is an important feature as there is only one marketed antibiotic for MRSA that can be taken orally.

MRSA has become a global public-health problem since the 1960s because of its resistance to antibiotics. In the United States alone, 278,000 people are hospitalized and 19,000 die each year from infections caused by MRSA. Only three drugs currently are effective treatments, and resistance to each of those drugs already exists.

The researchers have been seeking a solution to MRSA for years. "Professor Mobashery has been working on the mechanisms of resistance in MRSA for a very long time," Chang said. "As we understand what the mechanisms are, we can devise strategies to develop compounds against MRSA."

"Mayland Chang and Shahriar Mobashery's discovery of a class of compounds that combat drug resistant bacteria such as MRSA could save thousands of lives around the world. We are grateful for their leadership and persistence in fighting drug resistance," said Greg Crawford, dean of the College of Science at the University of Notre Dame.

###

Co-authors of the study include Peter O'Daniel, Zhihong Peng, Hualiang Pi, Sebastian Testero, Derong Ding, Edward Spink, Erika Leemans, Marc Boudreau, Takao Yamaguchi, Valerie Schroeder, William Wolter, Leticia Llarrull, Wei Song, Elena Lastochkin, Malika Kumarasiri, Nuno Antunes, Mana Espahbodi, Katerina Lichtenwalter, Mark Suckow, Sergei Vakulenko, Mobashery and Chang, from the Department of Chemistry and Biochemistry, the Freimann Life Sciences Center and the Department of Biological Sciences, all at the University of Notre Dame.

Mayland Chang | EurekAlert!

Further reports about: Discovery MRSA antibiotics chemists compounds drugs mechanisms resistance strategies

More articles from Life Sciences:

nachricht Singapore researchers discover a gene that increases incidence of AML
22.09.2014 | National University of Singapore

nachricht The accelerator of molecular motors
22.09.2014 | Ruhr-University Bochum

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Future questions regarding data processing

22.09.2014 | Event News

"Start-ups and spin-offs funding – Public and private policies", 14th October 2014

12.09.2014 | Event News

BALTIC 2014: Baltic Sea Geologists meet in Warnemünde

03.09.2014 | Event News

 
Latest News

Siemens D3 wind turbines ordered for onshore project in France

22.09.2014 | Press release

Wireless Sensor Transmits Tumor Pressure

22.09.2014 | Medical Engineering

UChicago-Argonne National Lab Team Improves Solar-Cell Efficiency

22.09.2014 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>